Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 1 / Phase 2	2025-08-19		NCT04910022

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Nerviano Medical Sciences	4

18 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Dana-Farber Cancer Institute	Boston	United States	626
Erasmus Medical Center	Rotterdam	Netherlands	7
IRCCS Istituto delle Scienze Neurologiche di Bologna	Bologna	Italy	5
IRCCS Istituto Neurologico Carlo Besta	Milan	Italy	6
Istituto Clinico Humanitas	Rozzano	Italy	50
Istituto Oncologico Veneto - IRCCS	Padova	Italy	10
Mayo Clinic Cancer Center	Rochester	United States	16
Mayo Clinic Florida	Jacksonville	United States	105
Mayo Clinic Hospital - Phoenix	Phoenix	United States	2
Memorial Sloan-Kettering Cancer Center	New York	United States	63
PanOncology Trials (Pan American Center for Oncology Trials, LLC)	Rio Piedras	Puerto Rico	1
Swedish Medical Center - First Hill Campus	Seattle	United States	2
The University of Texas MD Anderson Cancer Center	Houston	United States	207
University Hospital Zurich	Zurich	Switzerland	42
University of California Irvine Medical Center (UCIMC) - Chao Family Comprehensive Cancer Center	Orange	United States	2
University of Utah, University Hospital	Salt Lake City	United States	1
University of Virginia Health System	Charlottesville	United States	57
UT Southwestern Medical Center	Dallas	United States	210